BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Merck
Dow
Queensland Health
Cantor Fitzgerald
Cipla
Healthtrust
Boehringer Ingelheim
Medtronic

Generated: January 23, 2018

DrugPatentWatch Database Preview

SULFACETAMIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Sulfacetamide Sodium, and when can generic versions of Sulfacetamide Sodium launch?

Sulfacetamide Sodium is a drug marketed by Fougera Pharms, Perrigo Co Tennessee, Taro, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Pharmafair, and Sandoz Inc. and is included in twelve NDAs.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Drug patent expirations by year for SULFACETAMIDE SODIUM
Pharmacology for SULFACETAMIDE SODIUM
Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial

US Patents and Regulatory Information for SULFACETAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 077015-001 Nov 17, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alcon Pharms Ltd SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 089068-001 May 5, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Co Tennessee SULFACETAMIDE SODIUM sulfacetamide sodium OINTMENT;OPHTHALMIC 080029-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 073630-001 May 27, 1993 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040066-001 Dec 28, 1994 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Co Tennessee SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 078649-001 Mar 23, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 078668-001 May 20, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040216-001 May 25, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040215-001 May 25, 1999 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 089560-001 Oct 18, 1988 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Novartis
Colorcon
Fish and Richardson
Cantor Fitzgerald
Accenture
Moodys
Cerilliant
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot